Skin Care News

In this episode, host Hansa Bhargava, MD, talks with Julia Kerolus, MD, FACS, about the MedSpa industry, the dangers of social media and its effect on cosmetic procedures among young adults, skin care and more.

Topical microencapsulated benzoyl peroxide improved the skin microbiome and physical properties and clinical symptoms among patients with rosacea, according to results of a study published in Journal of Clinical and Aesthetic Dermatology.

The FDA approved Nemluvio in the form of a prefilled pen for subcutaneous injection for the treatment of prurigo nodularis in adults, Galderma announced in a press release.

Nemolizumab doses of 30 mg and 60 mg with topical corticosteroid treatment yielded positive results in adolescent patients with prurigo nodularis, according to a study.

Rapid itch reduction was positively correlated with treatment response among patients taking dupilumab for bullous pemphigoid, according to a study.

Optical coherence tomography may be able to guide treatment for port wine birthmarks that show wide variability in vessel density and size, but improvements are needed, according to a study.

Medicaid coverage for tretinoin is often granted for acne vulgaris but not pigmentary disorders, which disproportionately affect patients with skin of color, according to a study. Healio spoke with a dermatologist about these findings.

Omalizumab is effective and safe for the treatment of chronic urticaria, demonstrating high discontinuation due to well-controlled disease, according to a study.

In a new study published in the Journal of Drugs in Dermatology, researchers discussed how and why dermatologists have a significant role to play in the diagnosing and addressing of body dysmorphic disorder.

Healio has compiled July’s most-read news in dermatology.